Inspired by the potential of RNA interference (RNAi) in regulating gene expression,[9] the combination of chemotherapeutic agents with small interfering RNA (siRNA) towards TGF‐β (siTGF‐β) may present a promising treatment regimen for GBM. The gene discussed is TGFB1; the disease is glioblastoma.